IP Library › Granted Patent US 11,041,069
Granted Patent B2
US 11,041,069 · App. 16/179,698 · Granted Jun 22, 2021

Gene delivery carrier

Inventors: Umberto Capasso Palmiero (Zürich, CH); James C. Kaczmarek (Somerville, MA); Daniel Griffith Anderson (Framingham, MA); Davide Moscatelli (Arese, IT)
Assignees: Massachusetts Institute of Technology; Politecnico di Milano
C08L33/14A61K48/0041C08F20/34C08G63/6852C08G73/02C12N15/87C08L2201/06C08L2203/02C12N2310/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,041,069
App. No.
16/179,698
Granted
Jun 22, 2021
Kind
B2
Abstract

Disclosed are methods, compositions, reagents, systems, and kits to prepare and utilize poly (β-amino ester) (PBAE) polymers, which are synthesized via Michael addition reactions of diacrylates and amines disclosed herein. Various embodiments utilize lactones and lactone derivatives to generate the diacrylate compounds. The PBAE polymers are shown to be effective biodegradable carriers for the delivery of an agent such as an organic molecule, inorganic molecule, nucleic acid, protein, peptide, polynucleotide, targeting agent, an isotopically labeled chemical compound, vaccine, or an immunological agent.

Claims (72)

1. A polymer of Formula (I):

or a pharmaceutically acceptable salt thereof,

wherein:

is a single bond or a double bond;

A is hydrogen or —XR 3 ;

each B independently is a diradical of the formula:

each D independently is:

E is —XR 4 ;

R is C 2 -C 6 alkyl;

R′ is C 2 -C 20 alkyl, optionally substituted with a group selected from alkyl, heteroalkyl, alkenyl, alkynyl, haloalkyl, alkoxy, thioalkoxy, amino, alkylamino, dialkylamino, trialkylamino, acylamino, cyano, hydroxy, halo, mercapto, nitro, carboxyaldehyde, carboxy, alkoxycarbonyl, and carboxamide;

R″ cyclic or acyclic aliphatic, cyclic or acyclic heteroaliphatic, or a combination thereof, wherein each aliphatic or heteroaliphatic is optionally substituted with a C 1-6 alkyl;

each R a independently is hydrogen or C 1-6 alkyl;

each R 1 independently is selected from hydrogen, C 1 -C 10 alkyl, and C 1 -C 20 heteroalkyl, wherein the alkyl and heteroalkyl groups are optionally substituted with halogen, hydroxyl, C 3-10 carbocyclyl, 3-14 membered heterocyclyl, C 6-14 aryl, or 5-14 membered heteroaryl;

R 3 and R 4 independently are selected from hydrogen, C 1 -C 20 alkyl, C 1 -C 10 heteroalkyl, C 3-10 carbocyclyl, and 3-14 membered heterocyclyl;

X is O, S, NH, or NR X , wherein R X is C 1-6 alkyl;

X′ is O;

each m independently is an integer between 3 and 10, inclusive; and

n is an integer between 1 and 10,000, inclusive.

2. The polymer of claim 1 , having the structure of Formula (II):

3. The polymer of claim 1 , wherein B is of the formula:

4. The polymer of claim 1 , wherein m is an integer between 3 and 7, inclusive.

5. The polymer of claim 1 , wherein the polymer is of the formula:

wherein:

each R 1 is independently

at least one R 1 is

 and

at least one R 1 is

6. The polymer of claim 1 , wherein the polymer is of the formula:

wherein:

each R 1 is independently

at least one R 1 is

 and

at least one R 1 is

7. The polymer of claim 1 , wherein the polymer is of the formula:

wherein:

each R 1 is independently

at least one R 1 is

 and

at least one R 1 is

8. The polymer of claim 1 , wherein the polymer is of the formula:

wherein:

each D is independently

at least one D is

 and

at least one D is

9. The polymer of claim 1 , wherein the polymer has a molecular weight between 1-100 kDa.

10. A composition comprising a polymer of claim 1 and an excipient.

11. The composition of claim 10 , wherein the composition further comprises an agent.

12. The composition of claim 11 , wherein the agent is a polynucleotide.

13. The composition of claim 12 , wherein the polynucleotide is DNA.

14. The composition of claim 12 , wherein the polynucleotide is RNA.

15. The composition of claim 14 , wherein the RNA is dsRNA, siRNA, shRNA, miRNA, mRNA, or antisense RNA.

16. The composition of claim 14 , wherein the RNA is mRNA.

17. The composition of claim 16 , wherein the mRNA encodes an antigen.

18. The composition of claim 12 , wherein the polynucleotide carries out RNA interference.

19. The composition of claim 10 , wherein the composition is in the form of a particle.

20. The composition of claim 19 , wherein the particle encapsulates an agent.

21. The polymer of claim 5 , wherein:

m=3, n is about 5, each X is —NH—, and R 3 and R 4 are both

m=5, n is about 5, each X is —NH—, and R 3 and R 4 are both

or

m=7, n is about 5, each X is —NH—, and R 3 and R 4 are both

22. The polymer of claim 6 , wherein:

m=3, n is about 5, each X is —NH—, and R 3 and R 4 are both

m=5, n is about 5, each X is —NH—, and R 3 and R 4 are both

or

m=7, n is about 5, each X is —NH—, and R 3 and R 4 are both

23. The polymer of claim 7 , wherein:

m=3, n is about 5, each X is —NH—, and R 3 and R 4 are both

m=5, n is about 5, each X is —NH—, and R 3 and R 4 are both

or

m=7, n is about 5, each X is —NH—, and R 3 and R 4 are both

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2021
From: PALMIERO, UMBERTO CAPASSO
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY; POLITECNICO DI MILANO
Reel/Frame 055561/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2021
From: KACZMAREK, JAMES C.; ANDERSON, DANIEL GRIFFITH
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 055561/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2021
From: MOSCATELLI, DAVIDE
To: POLITECNICO DI MILANO
Reel/Frame 055561/0537 →
Continuity (3)
Provisional Application 62661864 · Apr 24, 2018
Provisional Application 62581277 · Nov 3, 2017
Related Publication 20190194444A1 · Jun 27, 2019
Cited By (1)
US 12,433,847